slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.845
KRW
|
-2,16%
|
|
-1,66%
|
-13,98%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
316.639
|
256.100
|
330.635
|
205.154
|
141.464
|
143.064
|
Bedrijfswaarde
1 |
344.459
|
292.037
|
352.787
|
228.295
|
151.265
|
156.080
|
K/w-verhouding
|
-30,8
x
|
5,97
x
|
-36,2
x
|
-17,3
x
|
14,8
x
|
5,46
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,7
x
|
1,85
x
|
2,31
x
|
1,23
x
|
0,73
x
|
0,65
x
|
Bedrijfswaarde/omzet
|
2,93
x
|
2,11
x
|
2,47
x
|
1,37
x
|
0,78
x
|
0,7
x
|
Bedrijfswaarde/EBITDA
|
-243
x
|
38,9
x
|
-125
x
|
-95,7
x
|
9,78
x
|
8,82
x
|
Bedrijfswaarde/FCF
|
-30,5
x
|
-33
x
|
30,7
x
|
36,4
x
|
77,3
x
|
40,4
x
|
FCF Yield
|
-3,28%
|
-3,03%
|
3,26%
|
2,75%
|
1,29%
|
2,47%
|
Price to Book
|
3,91
x
|
1,89
x
|
0,88
x
|
0,92
x
|
0,99
x
|
1,05
x
|
Aantal aandelen (in duizenden)
|
30.446
|
30.561
|
31.945
|
32.005
|
32.005
|
32.005
|
Referentieprijs
2 |
10.400
|
8.380
|
10.350
|
6.410
|
4.420
|
4.470
|
Datum van publicatie
|
19/03/19
|
18/03/20
|
23/03/21
|
23/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
117.475
|
138.083
|
143.023
|
166.567
|
193.379
|
221.725
|
EBITDA
1 |
-1.415
|
7.516
|
-2.812
|
-2.387
|
15.469
|
17.693
|
Bedrijfsresultaat (EBIT)
1 |
-4.529
|
3.396
|
-7.467
|
-7.427
|
10.377
|
11.849
|
Operationele Marge
|
-3,86%
|
2,46%
|
-5,22%
|
-4,46%
|
5,37%
|
5,34%
|
Resultaat voor belastingen (EBT)
1 |
-8.847
|
56.001
|
-8.340
|
-12.676
|
12.379
|
33.023
|
Nettowinst (verlies)
1 |
-10.218
|
43.646
|
-8.968
|
-11.854
|
9.561
|
26.211
|
Nettomarge
|
-8,7%
|
31,61%
|
-6,27%
|
-7,12%
|
4,94%
|
11,82%
|
WPA
2 |
-337,3
|
1.404
|
-285,6
|
-371,0
|
298,7
|
819,0
|
Free Cash Flow
1 |
-11.289
|
-8.839
|
11.489
|
6.272
|
1.958
|
3.863
|
FCF-marge
|
-9,61%
|
-6,4%
|
8,03%
|
3,77%
|
1,01%
|
1,74%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
12,66%
|
21,83%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
20,48%
|
14,74%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19/03/19
|
18/03/20
|
23/03/21
|
23/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
27.820
|
35.937
|
22.152
|
23.141
|
9.801
|
13.016
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-19,66
x
|
4,781
x
|
-7,878
x
|
-9,696
x
|
0,6336
x
|
0,7357
x
|
Free Cash Flow
1 |
-11.289
|
-8.839
|
11.489
|
6.272
|
1.958
|
3.863
|
ROE (netto-inkomsten/eigen vermogen)
|
-10,9%
|
37,4%
|
-3,43%
|
-3,68%
|
5,59%
|
19,3%
|
ROA (netto-inkomsten/totale activa)
|
-1,77%
|
1,02%
|
-1,2%
|
-1,05%
|
2,17%
|
3,02%
|
Totale activa
1 |
577.757
|
4.278.988
|
745.996
|
1.129.923
|
439.788
|
866.637
|
Nettoactief per aandeel
2 |
2.658
|
4.446
|
11.711
|
6.958
|
4.487
|
4.240
|
Cashflow per aandeel
2 |
487,0
|
324,0
|
448,0
|
381,0
|
572,0
|
679,0
|
Capex
1 |
4.034
|
4.636
|
3.012
|
2.749
|
4.193
|
4.797
|
Capex/omzet
|
3,43%
|
3,36%
|
2,11%
|
1,65%
|
2,17%
|
2,16%
|
Datum van publicatie
|
19/03/19
|
18/03/20
|
23/03/21
|
23/03/22
|
21/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -13,98% | 88,99 mln. | | +40,73% | 739 mld. | | +32,83% | 598 mld. | | -6,30% | 353 mld. | | +15,15% | 318 mld. | | +4,05% | 285 mld. | | +15,00% | 240 mld. | | +9,78% | 210 mld. | | -5,52% | 206 mld. | | +6,17% | 164 mld. |
Farmaceutische producten - Andere
|